June 5, 2023 8:24 PM
Latest:
  • Johnston Faces Criticism for Hiring Crisis Communications Firm on Taxpayer Expense
  • Two Safety Executives Leave Twitter Amid Content Moderation Concerns
  • Walgreens Introduces ‘Anti-Theft’ Store Design In Chicago
  • Court Validates IRS Access To Coinbase User Data Via “John Doe” Summons
  • Iraq’s Central Bank Announces Major Boost to National Gold Reserves
The Deep Dive

the deep dive

Providing stock analysis for investors of the Canadian junior markets

  • Home
  • Latest
    • Automotive
    • Latest
    • Cannabis
    • Commentary
    • Education
    • Full Analysis
    • Gold
    • Industrials
    • Macro
    • Oil
    • Psychedelics
    • Resources
    • Technology
  • Cannabis
  • Technology
  • Company Profiles
    • Hemlo Explorers
    • HydroGraph Clean Power
    • Power Nickel
    • Prime Meridian Resources
    • Riverside Resources
    • RooGold Inc
    • Slave Lake Zinc
    • Spey Resources
    • Trillion Energy
    • Vortex Metals
  • Resources
  • About
  • Contact Us
  • Advertise With Us

Compass Pathways

Biotech Latest 

Compass Pathways President Steps Down To An Advisory Role

December 16, 2021 11:18 AMDecember 16, 2021 10:56 AM ER Velasco 0 Comments Compass Pathways

Compass Pathways (Nasdaq: CMPS) announced this morning major changes to its executive team. One of its co-founders, President and Chief Business

Share
Tweet
Share
Read more
Latest Psychedelics 

Compass Pathways Granted Its Tenth Overall Patent Related To Psilocybin

November 23, 2021 7:55 AMNovember 23, 2021 7:55 AM Jay Lutz 0 Comments Compass Pathways

Compass Pathways (NASDAQ: CMPS) this morning issued a brief release, indicating it has been granted a fifth patent in the

Share
Tweet
Share
Read more
Latest Psychedelics 

Compass: Canaccord Reiterates $80 Price Target After Study Data

November 22, 2021 2:44 PMNovember 22, 2021 9:24 AM Justin Young 0 Comments Analyst Estimate, Compass Pathways

Earlier this month, Compass Pathways (Nasdaq: CMPS) announced positive topline results and its key findings in its Phase 2b clinical

Share
Tweet
Share
Read more
Biotech Latest 

Compass Pathways Sees “Reduction In Depressive Symptom” In Phase IIb Psilocybin Clinical Trial

November 9, 2021 12:33 PMNovember 9, 2021 12:05 PM ER Velasco 0 Comments Compass Pathways

Compass Pathways (Nasdaq: CMPS) announced today that its phase IIb clinical trial of COMP360 psilocybin therapy has achieved its primary endpoint.

Share
Tweet
Share
Read more
Biotech Latest 

Compass Pathways To Start Phase II Trial For Psilocybin PTSD Therapy

November 3, 2021 9:52 AMNovember 3, 2021 8:56 AM ER Velasco 0 Comments Compass Pathways

Compass Pathways (Nasdaq: CMPS) this morning announced that it will be launching the phase II clinical trial for its synthetic psilocybin

Share
Tweet
Share
Read more
Latest Psychedelics 

Compass Pathways Closes Enrollment For Phase IIb Psilocybin Clinical Trial

June 28, 2021 7:37 AMJune 28, 2021 7:37 AM Jay Lutz 0 Comments Compass Pathways, Psilocybin

Compass Pathways (NASDAQ: CMPS) this morning provided a brief update to the market on the latest status of its ongoing

Share
Tweet
Share
Read more
Latest Psychedelics 

Psychedelics: The Eight Capital Primer

June 14, 2021 3:38 PMJune 14, 2021 12:21 PM Justin Young 0 Comments Analyst Estimate, Bright Minds Biosciences, Compass Pathways, Cybin Inc, Field Trip Health, Mind Medicine, Mindset Pharma, Numinus Wellness Inc, Small Pharma Inc

Eight Capital recently produced a primer on the psychedelic sector saying that the companies are “poised to fill a growing

Share
Tweet
Share
Read more
Latest Psychedelics Video Series 

David Nutt: Amanita Muscaria Due For More Research – The Daily Dive

March 10, 2021 1:30 PMMarch 10, 2021 9:34 AM Jay Lutz 0 Comments Amanita Muscaria, Compass Pathways, Professor David Nutt, Psyched Wellness, The Daily Dive

Today on the Daily Dive, our host Cassandra Leah sits down with Dr David Nutt, a highly experienced neuropsychopharmacologist, the

Share
Tweet
Share
Read more
Latest Psychedelics Video Series 

Compass Pathways Leader Of Investment Climate For Psychedelic Plays – The Daily Dive feat Jeff Stevens

December 30, 2020 1:30 PMDecember 30, 2020 11:06 AM Jay Lutz 0 Comments Compass Pathways, Jeff Stevens, Psyched Wellness, The Daily Dive

Today on the Daily Dive, Jeff Stevens returns to the show to sit down with host Cassandra Leah to discuss

Share
Tweet
Share
Read more
Full Analysis Latest Psychedelics 

Psychedelics & The Need For Digital Therapeutic Solutions In Treating Mental Health

November 1, 2020 9:00 AMNovember 1, 2020 12:26 AM Jay Lutz 0 Comments Atai Life Sciences, Compass Pathways, Field Trip Health, Mind Cure Health, Mind Medicine

In terms of investment dollar inflows, one of the largest focuses of 2020 has arguably been that of the growing

Share
Tweet
Share
Read more
  • ← Previous

Latest

  • Johnston Faces Criticism for Hiring Crisis Communications Firm on Taxpayer Expense

  • Two Safety Executives Leave Twitter Amid Content Moderation Concerns

  • Walgreens Introduces ‘Anti-Theft’ Store Design In Chicago

  • Court Validates IRS Access To Coinbase User Data Via “John Doe” Summons

  • Iraq’s Central Bank Announces Major Boost to National Gold Reserves

  • 7 In 10 Canadians Still Want To Own A Home But Can’t Afford To

  • SEC Files Lawsuit Against Binance Holdings and its CEO for Alleged Rule Violations

  • Binance: Did Richard Teng Walk So Changpeng Zhao Could Run?

Video

Rudy Giuliani: Unmasking The Mayhem Behind The Mayor
Latest Macro Video Series 

Rudy Giuliani: Unmasking The Mayhem Behind The Mayor

June 4, 2023 11:24 AM Jay Lutz 0

Rudy Giuliani is one of my favourite politicians. No not because I agree with his politics, because he kind of

Trending

  • The Saga of Bob Lee & Cash App
  • Pirate Torrent Site RARBG Goes Down With Staff Plagued By COVID-19 And Russia-Ukraine War
  • Japan's Government Foregoes Copyright Enforcement on Data Used for AI Training
  • Cronos Group Exits Its US Operations After Spending $300 Million To Acquire Them During Height Of Cannabis Bubble
  • Trudeau Bends Over For Stellantis

News

First Phosphate Hits 110 Metres Of 7.02% P2O5 At Begin-Lamarche
Latest News Resources 

First Phosphate Hits 110 Metres Of 7.02% P2O5 At Begin-Lamarche

June 5, 2023 9:23 AM Jay Lutz 0

Drill results from a winter drill program conducted at First Phosphate’s (CSE: PHOS) Begin-Lamarche property in the Saguenay-Lac-St-jean region of Quebec were released this morning. The program saw a total of 4,274 metres drilled in aggregate across 20 holes.

Verses Proposes Regulatory Path For AI In New Report
Latest News Technology 

Verses Proposes Regulatory Path For AI In New Report

June 5, 2023 8:39 AM Jay Lutz 0
Trillion Energy Places Fifth Gas Well Into Production At SASB
Energy Latest News 

Trillion Energy Places Fifth Gas Well Into Production At SASB

June 1, 2023 9:54 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Menu

  • Home
  • About
  • Research
  • Discover
  • Contact Us
  • Disclaimer

Categories

  • Automotive
  • Biotech
  • Blockchain
  • Bonds
  • Cannabis
  • Commentary
  • Education
  • Energy
  • Entertainment
  • Esports
  • ETFs
  • Food
  • Full Analysis
  • Healthcare
  • Industrials
  • Latest
  • Lithium
  • Macro
  • Market Movers
  • Mental Hurdles
  • News
  • Oil
  • Politics
  • Psychedelics
  • Real Estate
  • Resources
  • Retail
  • SPACs
  • Technology
  • Video Series
Copyright © 2023 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.